Holen Sie sich die Stockscreener-App
2.21
6.36%
-0.15
Handel nachbörslich:
2.21
Schlusskurs vom Vortag:
$2.36
Offen:
$2.2401
24-Stunden-Volumen:
95,872
Relative Volume:
3.55
Marktkapitalisierung:
$90.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.92M
KGV:
-7.3667
EPS:
-0.3
Netto-Cashflow:
$-7.05M
1W Leistung:
-1.34%
1M Leistung:
-5.15%
6M Leistung:
+42.58%
1J Leistung:
+79.67%
1-Tages-Spanne:
$1.9124
$2.398
1-Wochen-Bereich:
$1.9124
$2.398
52-Wochen-Spanne:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Firmenname
Anebulo Pharmaceuticals Inc
Sektor
Branche
Telefon
737 203 5270
Adresse
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Vergleichen Sie ANEB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.21 | 96.96M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Anebulo Pharmaceuticals Inc Aktie (ANEB) Neueste Nachrichten
Is Anebulo Pharmaceuticals Inc. stock affected by interest rate hikesTrade Entry Report & Community Supported Trade Ideas - Улправда
Will Anebulo Pharmaceuticals Inc. stock pay special dividends2025 Winners & Losers & Free Reliable Trade Execution Plans - Улправда
Will Anebulo Pharmaceuticals Inc. stock reach Wall Street targetsQuarterly Investment Review & Community Trade Idea Sharing - Newser
Can Anebulo Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Volume Summary & Safe Capital Growth Tips - Newser
Anebulo Pharmaceuticals (NASDAQ:ANEB) Trading 0.8% HigherStill a Buy? - MarketBeat
Anebulo Pharmaceuticals (ANEB) Stock Analysis Report | Financials & Insights - Benzinga
Why retail investors pile into Anebulo Pharmaceuticals Inc. stock - BỘ NỘI VỤ
What drives Anebulo Pharmaceuticals Inc stock priceTechnical Resistance Breaks & Exceptional Profit Growth Tips - earlytimes.in
Will Anebulo Pharmaceuticals Inc. stock deliver strong dividend growthPortfolio Return Report & Weekly High Momentum Picks - newser.com
Will Anebulo Pharmaceuticals Inc. stock outperform value stocksJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
Can Anebulo Pharmaceuticals Inc. stock double in next 5 yearsRate Hike & Risk Managed Investment Entry Signals - newser.com
Will Anebulo Pharmaceuticals Inc. continue its uptrend2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is it too late to sell Anebulo Pharmaceuticals Inc.Gap Up & Reliable Entry Point Trade Alerts - newser.com
Has Anebulo Pharmaceuticals Inc. found a price floorPortfolio Return Report & Long-Term Growth Plans - newser.com
Risk vs reward if holding onto Anebulo Pharmaceuticals Inc.July 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
How Anebulo Pharmaceuticals Inc. stock valuations compare to rivalsPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Is Anebulo Pharmaceuticals Inc. stock supported by strong cash flows2025 Biggest Moves & Long-Term Investment Growth Plans - newser.com
Will Anebulo Pharmaceuticals Inc. stock beat EPS estimates2025 Big Picture & Free High Return Stock Watch Alerts - newser.com
Is Anebulo Pharmaceuticals Inc a good long term investmentEarnings Date Calendar & Outstanding Investment Trading - earlytimes.in
Is Anebulo Pharmaceuticals Inc. stock attractive for ETFsMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com
Quantitative breakdown of Anebulo Pharmaceuticals Inc. recent moveJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
Anebulo Pharmaceuticals Reports Q1 2026 Financial Results - MSN
[10-Q] Anebulo Pharmaceuticals, Inc. Quarterly Earnings Report | ANEB SEC FilingForm 10-Q - Stock Titan
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2025 - MarketScreener
Anebulo Pharmaceuticals posts Q1 net loss - MarketScreener
[8-K] Anebulo Pharmaceuticals, Inc. Reports Material Event | ANEB SEC FilingForm 8-K - Stock Titan
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates - Business Wire
Is Anebulo Pharmaceuticals Inc. stock ready for a breakoutProfit Target & Daily Technical Stock Forecast Reports - newser.com
What is the fair value of Anebulo Pharmaceuticals Inc. stock nowJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Finanzdaten der Anebulo Pharmaceuticals Inc-Aktie (ANEB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):